GM‐CSF Promotes Neutrophil PD‐L1 Expression Through the VEGFR‐2/STAT6/ CSF2 Signaling Axis in Oral Squamous Cell Carcinoma
Advanced Science · 2026-10 · 13 (60)
DOI: 10.1002/advs.76960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.08.2026. Verfasst von Fangxing Zhu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Oromaxillofacial Head and Neck Surgery, Center for Oromaxillofacial Head and Neck Disorders, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Granulocyte-Macrophage Colony-Stimulating Factor, Mouth Neoplasms, Neutrophils, Vascular Endothelial Growth Factor Receptor-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seed Program for Research and Translation of New Medical Technologies of Shanghai Municipal Health Commission, National Natural Science Foundation of China, Excellent Academic Leader Program of Shanghai Oriental Talent Plan.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) remains a highly aggressive malignancy with limited responsiveness to anti‐PD‐1 immunotherapy. Recent neoadjuvant studies combining VEGFR‐2 inhibition (VEGFR2i) with anti‐PD‐1 (aPD‐1) have yielded markedly improved pathological responses, suggesting a VEGFR‐2‐dependent immunoregulatory mechanism. Here, we identify a PD‐L1‐expressing CD66b + neutrophil‐enriched tumor‐associated population as a critical immunosuppressive population enriched in VEGFR‐2‐high OSCC tumors and associated with increased metastatic propensity and inferior patient outcomes. Using multiplex immunohistochemistry, scRNA‐seq, and flow cytometry, we demonstrate that VEGFR‐2‐overexpressing OSCC cells drive robust GM‐CSF secretion, which in turn induces PD‐L1 upregulation in neutrophils. Mechanistically, VEGFR‐2 activation promotes STAT6 phosphorylation and nuclear translocation, enabling direct transcriptional activation of CSF2 . GM‐CSF subsequently activates STAT5 and mTOR/S6K signaling in neutrophils, thereby enhancing PD‐L1 protein synthesis. Functionally, these PD‐L1 + TANs suppress CD8 + T‐cell proliferation, augment T‐cell exhaustion, and diminish cytotoxicity. Importantly, VEGFR‐2 inhibition or GM‐CSF neutralization restored CD8 + T‐cell function and improved responsiveness to anti‐PD‐1 therapy in vivo, whereas exogenous GM‐CSF impaired VEGFR2i/aPD‐1 efficacy. Collectively, our findings reveal a previously unrecognized VEGFR‐2/STAT6/ CSF2 axis that licenses neutrophil‐mediated immune suppression in OSCC. These data provide mechanistic rationale and preclinical support for targeting the VEGFR‐2/GM‐CSF‐neutrophil axis to improve the efficacy of PD‐1 blockade in OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oromaxillofacial Head and Neck Surgery, Center for Oromaxillofacial Head and Neck Disorders, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Oral & Maxillofacial-Head & Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- College of Stomatology, Shanghai Jiao Tong University, Shanghai, China.
- National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai, China.
- Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai, China.
- Department of Oral Pathology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Fangxing Zhu, Yibin Dai, Yingying Huang, Tongchao Zhao
Förderung
- Seed Program for Research and Translation of New Medical Technologies of Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Excellent Academic Leader Program of Shanghai Oriental Talent Plan
- Clinical Scientist Development Program of Fudan University
- Shanghai Sailing Program grant
- Project of Shanghai Huangpu District Science and Technology Commission
- Real-world research charity project on clinical nutrition management for cancer patients
- 2025 Shanghai Municipal Health Commission Special Project for Clinical Research in the Health Sector
Zitieren
APA
Zhu, F., You, Y., Zhang, Y., Dai, Y., Zhou, X., Fu, Y., Lu, X., Huang, Y., Zhou, Z., Xia, R., Ju, W., Yuan, Z., Zhong, L., & Zhao, T. (2026). GM‐CSF Promotes Neutrophil PD‐L1 Expression Through the VEGFR‐2/STAT6/ CSF2 Signaling Axis in Oral Squamous Cell Carcinoma. Advanced Science, 13(60). https://doi.org/10.1002/advs.76960
Vancouver
Zhu F, You Y, Zhang Y, Dai Y, Zhou X, Fu Y, et al. GM‐CSF Promotes Neutrophil PD‐L1 Expression Through the VEGFR‐2/STAT6/ CSF2 Signaling Axis in Oral Squamous Cell Carcinoma. Advanced Science. 2026;13(60). doi:10.1002/advs.76960
BibTeX
@article{Zhu2026,
author = {Zhu, Fangxing and You, Yuanhe and Zhang, Yiyi and Dai, Yibin and Zhou, Xinyu and Fu, Yong and Lu, Xi and Huang, Yingying and Zhou, Zhihang and Xia, Ronghui and Ju, Wutong and Yuan, Zhaoqi and Zhong, Laiping and Zhao, Tongchao},
title = {GM‐CSF Promotes Neutrophil PD‐L1 Expression Through the VEGFR‐2/STAT6/ CSF2 Signaling Axis in Oral Squamous Cell Carcinoma},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {60},
doi = {10.1002/advs.76960}
}
EUVIMED